No controlled trials of therapy for invasive aspergillosis have been done. This review
appraises 2,121 cases reported in 497 articles in the literature and analyzes 440 courses of …

A review of series of⩾ 4 cases of invasive aspergillosis (total, 1,223 cases) was undertaken
to establish the crude mortality and rate of response to therapy with amphotericin B in the …

Aspergillus was first recognized as an organism by Micheli in 1729. The first description of
disease due to Aspergillus was in the air sacs and lungs of a jackdaw in 1815, and the first …

Invasive aspergillosis is generally a life-threatening invasive opportunistic mycosis affecting
principally the upper and lower respiratory tract. Therapeutic response rates vary …

Aspergillosis comprises a variety of manifestations of infection. These guidelines are
directed to 3 principal entities: invasive aspergillosis, involving several organ systems …

Since the first description of invasive aspergillosis as an opportunistic infection in 1953 [1],
there has been a substantial increase in the number of cases documented at autopsy in all …

Standard antifungal medical therapy of invasive pulmonary aspergillosis that occurs in
immunocompromised patients with hematologic diseases with neutropenia or in liver …

Ninety-one patients with documented invasive infections due to an Aspergillus species were
identified at Memorial Sloan-Kettering Cancer Center from July 1, 1971, through December …

The term “aspergillosis” comprises several categories of infection: invasive aspergillosis;
chronic necrotizing aspergillosis; aspergilloma, or fungus ball; and allergic …

Orbital aspergillosis is an uncommon but serious infection that may first present to the
ophthalmologist. Usually arising from the paranasal sinuses, it may present in manifold ways …